Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARCUS E MCKENZIE

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1588640213
CMS profile
26396
Location
PLANO, TX

General Payments · PY2018–2024

$5,056.94

  • Reported across 275 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$666.10

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $666.10 35

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $465.85 28
PY2019 $661.66 44
PY2020 $307.89 18
PY2021 $944.76 62
PY2022 $1,067.34 43
PY2023 $943.34 45
PY2024 $666.10 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $29.21 04/24/2024 Food and Beverage Undisputed 01/23/2026 1111648386 CMS
Azurity Pharmaceuticals, Inc. $14.02 08/14/2024 Food and Beverage Undisputed 01/23/2026 1134009653 CMS
Baxter Healthcare $19.65 11/12/2024 Food and Beverage Undisputed 01/23/2026 1120665162 CMS
E.R. Squibb & Sons, L.L.C. $18.71 12/03/2024 Food and Beverage Undisputed 01/23/2026 1101396995 CMS
Kiniksa Pharmaceuticals International, plc $20.72 03/05/2024 Food and Beverage Undisputed 01/23/2026 1154889949 CMS
Kiniksa Pharmaceuticals International, plc $18.23 04/02/2024 Food and Beverage Undisputed 01/23/2026 1154889969 CMS
Kiniksa Pharmaceuticals International, plc $19.39 05/08/2024 Food and Beverage Undisputed 01/23/2026 1154889987 CMS
Kiniksa Pharmaceuticals International, plc $17.87 06/04/2024 Food and Beverage Undisputed 01/23/2026 1154890009 CMS
Kiniksa Pharmaceuticals International, plc $24.46 07/02/2024 Food and Beverage Undisputed 01/23/2026 1154890023 CMS
Kiniksa Pharmaceuticals International, plc $18.83 09/05/2024 Food and Beverage Undisputed 01/23/2026 1154890047 CMS
Merck Sharp & Dohme LLC $18.62 01/31/2024 Food and Beverage Undisputed 01/23/2026 1141564678 CMS
Merck Sharp & Dohme LLC $20.84 10/16/2024 Food and Beverage Undisputed 01/23/2026 1141911324 CMS
Novartis Pharmaceuticals Corporation $19.15 01/10/2024 Food and Beverage Undisputed 01/23/2026 1087045356 CMS
Novartis Pharmaceuticals Corporation $19.88 02/14/2024 Food and Beverage Undisputed 01/23/2026 1087045360 CMS
Novartis Pharmaceuticals Corporation $25.01 04/08/2024 Food and Beverage Undisputed 01/23/2026 1087045364 CMS
Novartis Pharmaceuticals Corporation $13.24 04/15/2024 Food and Beverage Undisputed 01/23/2026 1087045368 CMS
Novartis Pharmaceuticals Corporation $21.23 05/22/2024 Food and Beverage Undisputed 01/23/2026 1087045370 CMS
Novartis Pharmaceuticals Corporation $24.49 06/28/2024 Food and Beverage Undisputed 01/23/2026 1087045372 CMS
Novartis Pharmaceuticals Corporation $16.20 07/26/2024 Food and Beverage Undisputed 01/23/2026 1087045376 CMS
Novartis Pharmaceuticals Corporation $18.88 08/14/2024 Food and Beverage Undisputed 01/23/2026 1087045378 CMS
Novartis Pharmaceuticals Corporation $20.61 09/11/2024 Food and Beverage Undisputed 01/23/2026 1087045380 CMS
Novartis Pharmaceuticals Corporation $21.78 10/30/2024 Food and Beverage Undisputed 01/23/2026 1087045382 CMS
Novartis Pharmaceuticals Corporation $23.30 11/20/2024 Food and Beverage Undisputed 01/23/2026 1087045384 CMS
Novo Nordisk Inc $16.07 01/05/2024 Food and Beverage Undisputed 01/23/2026 1096946226 CMS
Novo Nordisk Inc $15.51 03/06/2024 Food and Beverage Undisputed 01/23/2026 1097639654 CMS
Novo Nordisk Inc $14.28 07/16/2024 Food and Beverage Undisputed 01/23/2026 1097747458 CMS
Novo Nordisk Inc $15.63 08/20/2024 Food and Beverage Undisputed 01/23/2026 1096703261 CMS
Novo Nordisk Inc $20.70 09/25/2024 Food and Beverage Undisputed 01/23/2026 1097452104 CMS
Novo Nordisk Inc $13.77 10/09/2024 Food and Beverage Undisputed 01/23/2026 1096981112 CMS
PFIZER INC. $18.87 03/19/2024 Food and Beverage Undisputed 01/23/2026 1131294092 CMS
PFIZER INC. $18.66 04/25/2024 Food and Beverage Undisputed 01/23/2026 1131410776 CMS
SANOFI-AVENTIS U.S. LLC $18.14 02/27/2024 Food and Beverage Undisputed 01/23/2026 1139674983 CMS
SANOFI-AVENTIS U.S. LLC $18.11 05/08/2024 Food and Beverage Undisputed 01/23/2026 1139675029 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $24.03 09/26/2024 Food and Beverage Undisputed 01/23/2026 1080654921 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $8.01 10/15/2024 Food and Beverage Undisputed 01/23/2026 1080654925 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.